CoChat
Sign Up
Cited by 81

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Pan-cancer analysis reveals cooperativity of both strands of microRNA that regulate tumorigenesis and patient survival

Mitra, Ramkrishna, Adams, Clare M., Jiang, Wei, Greenawalt, Evan, Eischen, Christine M.·2020·Nature Communications
DOI 10.1038/s41467-020-14713-2PMC PMC7033124
Open this paper in CoChat — free account

Abstract

Recently, both 5p and 3p miRNA strands are being recognized as functional instead of only one, leaving many miRNA strands uninvestigated. To determine whether both miRNA strands, which have different mRNA-targeting sequences, cooperate to regulate pathways/functions across cancer types, we evaluate genomic, epigenetic, and molecular profiles of >5200 patient samples from 14 different cancers, and RNA interference and CRISPR screens in 290 cancer cell lines. We identify concordantly dysregulated miRNA 5p/3p pairs that coordinately modulate oncogenic pathways and/or cell survival/growth across cancers. Down-regulation of both strands of miR-30a and miR-145 recurrently increased cell cycle pathway genes and significantly reduced patient survival in multiple cancers. Forced expression of all four strands show cooperativity, reducing cell cycle pathways and inhibiting lung cancer cell proliferation and migration. Therefore, we identify miRNA whose 5p/3p strands function together to regulate core tumorigenic processes/pathways and reveal a previously unknown pan-cancer miRNA signature with patient prognostic power.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-020-14713-2

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Show all 5 references

Research works printed but not linked: 53

  1. Drusco, A. & Croce, C. M. MicroRNAs and cancer: a long story for short RNAs. Adv. Cancer Res. 135, 1–24 (2017). · DOI
  2. Alles, J. et al. An estimate of the total number of true human miRNAs. Nucleic Acids Res. 47, 3353–3364 (2019). · DOI · Paper page
  3. Kozomara, A. & Griffiths-Jones, S. miRBase: annotating high confidence microRNAs using deep sequencing data. Nucleic Acids Res. 42, D68–D73 (2014). · DOI · Paper page
  4. Kozomara, A., Birgaoanu, M. & Griffiths-Jones, S. miRBase: from microRNA sequences to function. Nucleic Acids Res. 47, D155–D162 (2019). · DOI · Paper page
  5. Mitra, R., Lin, C. C., Eischen, C. M., Bandyopadhyay, S. & Zhao, Z. Concordant dysregulation of miR-5p and miR-3p arms of the same precursor microRNA may be a mechanism in inducing cell proliferation and tumorigenesis: a lung cancer study. RNA 21, 1055–1065 (2015). · DOI
  6. Mitra, R., Sun, J. & Zhao, Z. microRNA regulation in cancer: One arm or two arms? Int J. Cancer 137, 1516–1518 (2015). · DOI
  7. Jacobsen, A. et al. Analysis of microRNA-target interactions across diverse cancer types. Nat. Struct. Mol. Biol. 20, 1325–1332 (2013). · DOI
  8. Wu, X. L. et al. MicroRNA-143 suppresses gastric cancer cell growth and induces apoptosis by targeting COX-2. World J. Gastroenterol. 19, 7758–7765 (2013). · DOI
  9. Fornari, F. et al. MiR-199a-3p regulates mTOR and c-Met to influence the doxorubicin sensitivity of human hepatocarcinoma cells. Cancer Res. 70, 5184–5193 (2010). · DOI
  10. Lin, M. H. et al. Comprehensive identification of microRNA arm selection preference in lung cancer: miR-324-5p and -3p serve oncogenic functions in lung cancer. Oncol. Lett. 15, 9818–9826 (2018).
  11. Tsang, F. H. et al. MicroRNA-142-3p and microRNA-142-5p are downregulated in hepatocellular carcinoma and exhibit synergistic effects on cell motility. Front. Med. 9, 331–343 (2015). · DOI
  12. Qin, D. et al. MicroRNA-223-5p and -3p cooperatively suppress necroptosis in ischemic/reperfused hearts. J. Biol. Chem. 291, 20247–20259 (2016). · DOI
  13. Uchino, K. et al. Therapeutic effects of microRNA-582-5p and -3p on the inhibition of bladder cancer progression. Mol. Ther. 21, 610–619 (2013). · DOI
  14. Almeida, M. I. et al. Strand-specific miR-28-5p and miR-28-3p have distinct effects in colorectal cancer cells. Gastroenterology 142, 886–896 e889 (2012). · DOI · Paper page
  15. Chang, K. W. et al. Passenger strand miRNA miR-31* regulates the phenotypes of oral cancer cells by targeting RhoA. Oral. Oncol. 49, 27–33 (2013). · DOI
  16. Shan, S. W. et al. Mature miR-17-5p and passenger miR-17-3p induce hepatocellular carcinoma by targeting PTEN, GalNT7 and vimentin in different signal pathways. J. Cell Sci. 126, 1517–1530 (2013). · DOI
  17. Yang, X. et al. Both mature miR-17-5p and passenger strand miR-17-3p target TIMP3 and induce prostate tumor growth and invasion. Nucleic Acids Res. 41, 9688–9704 (2013). · DOI
  18. Zhang, Z. et al. microRNA arm-imbalance in part from complementary targets mediated decay promotes gastric cancer progression. Nat. Commun. 10, 4397 (2019). · DOI · Paper page
  19. Hamilton, M. P. et al. Identification of a pan-cancer oncogenic microRNA superfamily anchored by a central core seed motif. Nat. Commun. 4, 2730 (2013). · DOI
  20. Benjamini, Y. & Hochberg, Y. Controlling the false discovery rate-a practical and powerful approach to multiple testing. J. R. Stat. Soc. Ser. B-Methodol. 57, 289–300 (1995). · DOI · Paper page
  21. Tsherniak, A. et al. Defining a cancer dependency map. Cell 170, 564–576 e516 (2017). · DOI · Paper page
  22. McFarland, J. M. et al. Improved estimation of cancer dependencies from large-scale RNAi screens using model-based normalization and data integration. Nat. Commun. 9, 4610 (2018). · DOI
  23. Meyers, R. M. et al. Computational correction of copy number effect improves specificity of CRISPR-Cas9 essentiality screens in cancer cells. Nat. Genet. 49, 1779–1784 (2017). · DOI · Paper page
  24. Zhang, B., Kirov, S. & Snoddy, J. WebGestalt: an integrated system for exploring gene sets in various biological contexts. Nucleic Acids Res. 33, W741–W748 (2005). · DOI
  25. Kanehisa, M. & Goto, S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28, 27–30 (2000). · DOI · Paper page
  26. Westermarck, J. & Kahari, V. M. Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J. 13, 781–792 (1999). · DOI
  27. Page-McCaw, A., Ewald, A. J. & Werb, Z. Matrix metalloproteinases and the regulation of tissue remodelling. Nat. Rev. Mol. Cell Biol. 8, 221–233 (2007). · DOI · Paper page
  28. Garbicz, F. et al. Increased expression of the microRNA 106b~25 cluster and its host gene MCM7 in corticotroph pituitary adenomas is associated with tumor invasion and Crooke’s cell morphology. Pituitary 20, 450–463 (2017). · DOI
  29. Bjaanaes, M. M. et al. Unique microRNA-profiles in EGFR-mutated lung adenocarcinomas. Int J. Cancer 135, 1812–1821 (2014). · DOI
  30. Barrett, T. & Edgar, R. Gene expression omnibus: microarray data storage, submission, retrieval, and analysis. Methods Enzymol. 411, 352–369 (2006). · DOI
  31. Fabregat, A. et al. The reactome pathway knowledgebase. Nucleic Acids Res. 46, D649–D655 (2018). · DOI
  32. Barbie, D. A. et al. Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1. Nature 462, 108–112 (2009). · DOI
  33. Misono, S. et al. Dual strands of the miR-145 duplex (miR-145-5p and miR-145-3p) regulate oncogenes in lung adenocarcinoma pathogenesis. J. Hum. Genet. 63, 1015–1028 (2018). · DOI
  34. Mataki, H. et al. Dual-strand tumor-suppressor microRNA-145 (miR-145-5p and miR-145-3p) coordinately targeted MTDH in lung squamous cell carcinoma. Oncotarget 7, 72084–72098 (2016). · DOI
  35. Matsushita, R. et al. Regulation of UHRF1 by dual-strand tumor-suppressor microRNA-145 (miR-145-5p and miR-145-3p): Inhibition of bladder cancer cell aggressiveness. Oncotarget 7, 28460–28487 (2016). · DOI
  36. Yuan, Y. et al. Overexpression of miR-30a in lung adenocarcinoma A549 cell line inhibits migration and invasion via targeting EYA2. Acta Biochim. Biophys. Sin. (Shanghai) 48, 220–228 (2016). · DOI
  37. Hart, T. et al. High-resolution CRISPR screens reveal fitness genes and genotype-specific cancer liabilities. Cell 163, 1515–1526 (2015). · DOI · Paper page
  38. Del Carratore, F. et al. RankProd 2.0: a refactored bioconductor package for detecting differentially expressed features in molecular profiling datasets. Bioinformatics 33, 2774–2775 (2017). · DOI
  39. Breitling, R., Armengaud, P., Amtmann, A. & Herzyk, P. Rank products: a simple, yet powerful, new method to detect differentially regulated genes in replicated microarray experiments. FEBS Lett. 573, 83–92 (2004). · DOI
  40. Shaffer, A. L. et al. Signatures of the immune response. Immunity 15, 375–385 (2001). · DOI
  41. Liu, S. S. et al. Oncogenic microRNA signature for early diagnosis of cervical intraepithelial neoplasia and cancer. Mol. Oncol. 12, 2009–2022 (2018). · DOI
  42. Mitra, R. et al. Reproducible combinatorial regulatory networks elucidate novel oncogenic microRNAs in non-small cell lung cancer. RNA 20, 1356–1368 (2014). · DOI
  43. Mitra, R. et al. Decoding critical long non-coding RNA in ovarian cancer epithelial-to-mesenchymal transition. Nat. Commun. 8, 1604 (2017). · DOI
  44. Jia, D., Jolly, M. K., Kulkarni, P. & Levine, H. Phenotypic plasticity and cell fate decisions in cancer: insights from dynamical systems theory. Cancers (Basel) 9, pii: E70 (2017). · DOI
  45. Lim, E. L. et al. Comprehensive miRNA sequence analysis reveals survival differences in diffuse large B-cell lymphoma patients. Genome Biol. 16, 18 (2015). · DOI
  46. Robinson, M. D., McCarthy, D. J. & Smyth, G. K. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26, 139–140 (2010). · DOI · Paper page
  47. Mestdagh, P. et al. A novel and universal method for microRNA RT-qPCR data normalization. Genome Biol. 10, R64 (2009). · DOI · Paper page
  48. Agarwal V., Bell G. W., Nam J. W. & Bartel D. P. Predicting effective microRNA target sites in mammalian mRNAs. Elife 4, e05005 (2015). · DOI · Paper page
  49. Bandyopadhyay, S. & Mitra, R. TargetMiner: microRNA target prediction with systematic identification of tissue-specific negative examples. Bioinformatics 25, 2625–2631 (2009). · DOI
  50. Chou, C. H. et al. miRTarBase update 2018: a resource for experimentally validated microRNA-target interactions. Nucleic Acids Res. 46, D296–D302 (2018). · DOI
  51. Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 59, 15–21 (2013). · DOI · Paper page
  52. Anders, S., Pyl, P. T. & Huber, W. HTSeq—a Python framework to work with high-throughput sequencing data. Bioinformatics 31, 166–169 (2015). · DOI · Paper page
  53. Greenawalt, E. J. et al. Targeting of SGK1 by miR-576-3p inhibits lung adenocarcinoma migration and invasion. Mol. Cancer Res. 17, 289–298 (2019). · DOI

Cited by

Sorted by citations

See all 81

Metadata

Authors
Mitra, R., Adams, C. M., Jiang, W., Greenawalt, E., & Eischen, C. M.
ORCID
Venue
Nature Communications
Publisher
Springer Science and Business Media LLC
Published
2020-02-20
Volume
11
Issue
1
ISSN
2041-1723
DOI
10.1038/s41467-020-14713-2
PMC
PMC7033124
Cited by
81
References
5
Language
en
Licence
Funders
U.S. Department of Health & Human Services | NIH | National Cancer Institute (R01CA177786, P30CA056036)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review